Methanobrevibacter Smithii

If you have constipation and bloating that hasn't responded to fiber, water, or the usual advice, one possible reason is that a specific microbe in your colon is producing methane gas. Methane slows intestinal transit. The more of this organism you carry, the more methane you make, and the fewer bowel movements you tend to have.

That organism is M. smithii (Methanobrevibacter smithii). Almost everyone has it. What matters is how much, and this test counts it. One thing to know upfront: this is a research-grade measurement without agreed clinical cutoffs, so the number is most useful as one piece of a picture that includes your symptoms and, ideally, a breath test.

Why Standard Stool Tests Miss It

M. smithii belongs to the archaea, a separate branch of life from bacteria. That distinction is not trivia. It explains why standard stool cultures miss it entirely, why routine gastrointestinal pathogen panels don't look for it, and why some antibiotics that work on bacteria have little effect on it. A clean stool culture or a negative pathogen panel tells you nothing about your methanogen load.

The organism is a single cell with no nucleus, and it lives mainly in the colon. It arrives early: it has been found in newborn stomachs and in the first stool of preterm infants, and it can be cultured from human colostrum and breast milk. You didn't catch it. It's part of the normal human ecosystem.

Its job is to clean up hydrogen. When gut bacteria ferment fiber and carbohydrates, they release hydrogen gas. If hydrogen builds up, fermentation itself starts to stall. M. smithii consumes that hydrogen and combines it with carbon dioxide to make methane, which you then breathe out. This is why it partners closely with fiber-fermenting bacteria like Christensenellaceae and Ruminococcaceae: they make the fuel it runs on.

Constipation and Methane

The clearest use of this test is in constipation-predominant irritable bowel syndrome (IBS-C), where methane is not a bystander. It acts on the gut's neuromuscular machinery to slow transit.

The pattern across studies is consistent in direction, though the absolute counts shift with the lab method. In one cohort of people with IBS-C, the typical stool count ran around a million copies per gram. In healthy controls it was under a hundred. In diarrhea-predominant IBS, a couple of thousand. That puts constipated IBS on the order of ten thousand times higher than healthy, and other cohorts report the same gap on a different numeric scale. In a separate cohort, M. smithii was detectable in 88.1% of IBS-C subjects versus 17.9% of those with the diarrhea subtype.

Stool load also tracks what you breathe out. Fecal abundance correlates with exhaled methane in the 0.5 to 0.7 range, where 1.0 would be a perfect match, and it runs opposite to how often you have a bowel movement. In one study, a cutoff near a million copies per gram separated people who had detectable breath methane from those who didn't: it caught 64 out of 100 with methane and correctly cleared 86 out of 100 without it. That is a research cutoff from a single study, not a validated clinical threshold, and it doesn't transfer cleanly to a number from a different lab.

So if you have chronic constipation and bloating and a high count here, methane overproduction is a plausible driver rather than a coincidence. That reframes the problem. Adding more fiber feeds the hydrogen supply this organism runs on, which is one reason the standard constipation advice sometimes makes bloating worse.

When the Number Goes the Other Way

A low or undetectable result is not automatically good news. In children with severe acute malnutrition, M. smithii was found in only 4.2% of cases compared with 40.9% of controls. The organism appears to be part of how the gut extracts energy from food, and losing it accompanies metabolic failure rather than protecting against it.

The same downward pattern shows up in active inflammatory bowel disease. Methanogens are consistently less common in people with Crohn's disease and ulcerative colitis than in healthy people, with carriage around 30% in Crohn's and 24% in ulcerative colitis in one analysis, and pediatric cohorts show depletion during active disease. Inflamed gut tissue is a poor home for an organism that needs strictly oxygen-free conditions. Kidney transplant recipients show it too: colonization dropped to 28.6% versus 86.4% in comparison subjects.

So this is not a marker where less is better and more is worse. A high number and a very low number both carry information, and they point at different problems. A high count usually means slow, methane-heavy fermentation. A very low count often means the gut environment has turned hostile to normal oxygen-free life, whether from inflammation, drugs, or malnutrition. Neither reading is a diagnosis on its own.

Body Weight Cuts Both Ways Too

The popular story is that methanogens harvest extra calories and make you gain weight. The evidence is mixed, and the contradiction is worth understanding before you read your own result.

In children, higher colonization above 7 log copies per gram was linked to being overweight, roughly three times the odds compared with lower colonization. But adults with anorexia nervosa show enriched M. smithii, not depleted. And competitive cyclists, who are neither malnourished nor overweight, carry it commonly.

The framework that makes these fit: methanogen abundance tracks how slowly and how completely material ferments in the colon, not body fat directly. Slow transit and high fiber intake both favor it, which is what you see in anorexia. Efficient energy extraction during growth may favor it too, which is what you see in the childhood weight data. Don't read a high result as an explanation for your weight.

Why a Single Reading Can Fool You

The biggest limitation here is technical, not biological. This organism has a tough cell wall that resists standard DNA extraction. Older lab protocols underestimated it by a hundred- to a thousandfold and reported healthy people as negative when they weren't. With harsher physical disruption and overnight enzyme digestion of the sample, detection in healthy adults rises to 95.7%. Two labs can report very different numbers from the same stool.

A few other things shift the reading without meaning much:

• Stool water content: looser stool dilutes the count. Quantitative profiling studies identify stool moisture as one of the strongest drivers of day-to-day microbiome variability, and most gut genera vary substantially from day to day.
• Where you live: rural populations carry more of this organism than urban ones, and geography, ethnicity, and diet all shift baseline abundance. There is no single normal.
• Recent antibiotics or critical illness: intensive care patients on broad-spectrum antibiotics lose gut microbial diversity dramatically. Testing soon after a hospital stay or a course of antibiotics gives you a snapshot of disruption, not your baseline.
• Age: methanogen abundance shifts across the lifespan, rising into older age, so comparing your number against a generic adult figure can mislead.

Tracking Your Trend

Because there are no validated cutoffs and lab methods vary, a single number in isolation tells you less than the direction of travel. Your own baseline is the reference range you actually have.

Get a baseline while symptoms are stable and you haven't had antibiotics for at least a month. If you're changing your diet or working on constipation, retest a few months later and see whether the count moved alongside your symptoms. Use the same lab every time. Switching labs mid-track means comparing two different extraction protocols, and the difference between them can be larger than any real biological change.

One caveat about tracking treatment: the intervention evidence is thin. One non-randomized trial in 21 adults found that a probiotic reduced Methanobrevibacter abundance and flatulence. That is a small, uncontrolled study, and it is close to the whole of the direct human intervention literature for this organism.

What to Do With an Unexpected Result

If your count is high, the single most useful next step is a breath test. A fasting breath methane measurement at or above 10 parts per million caught about 86 out of 100 cases of intestinal methanogen overgrowth and flagged no one without it. Breath testing shows whether the organism is actively making gas right now, which counting DNA in stool cannot. The stool count, in turn, picks up people whose numbers sit below the level where methane shows up in breath. The two tests answer different questions, and having both is far more informative than either alone.

High count plus constipation plus a positive methane breath test is a coherent picture worth acting on with a gastroenterologist, since the treatments for methanogen overgrowth are prescription antimicrobials and the regimens differ from those used for bacterial overgrowth. The evidence behind those regimens is limited and partly conflicting, so treatment is a judgment call rather than a protocol. High count with no symptoms is most likely just your ecology, and does not need treating.

If your count is very low or undetectable, the question shifts to whether something is suppressing your gut ecosystem. Order fecal calprotectin alongside it: calprotectin measures inflammation in the gut lining and helps separate a functional problem from active inflammatory bowel disease, where methanogens drop. A stool pathogen panel rules out an infection driving the picture. If calprotectin is elevated and you have blood in your stool, weight loss, or persistent diarrhea, that combination warrants a gastroenterologist and likely a colonoscopy, not more microbiome testing.

And if the result is unremarkable but your symptoms aren't, do not treat this test as the final word. It profiles one organism in an ecosystem of thousands.